
|Articles|December 1, 2001
Eyetracking system approved
The FDA has given Bausch & Lomb approval to market its Active EyetrackingSystem in the United States.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Advancements in laser refractive surgery
2
From then to next: Five decades of transformation in ophthalmology
3
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
4
Kodiak Sciences releases follow-up, 20-week data from APEX study
5


















































.png)


